Similar articles for PMID: 16475711

Year	Number of Results
1979	1
1980	1
1982	1
1987	1
1990	5
1991	2
1992	1
1993	2
1994	1
1995	1
1997	1
1998	1
1999	2
2000	4
2001	6
2002	2
2003	2
2004	2
2005	5
2006	13
2007	14
2008	11
2009	4
2019	1
2022	0

1

In vivo antitumour effect of combretastatin A-4 phosphate added to fractionated irradiation.

Ahmed B, Landuyt W, Griffioen AW, Van Oosterom A, Van den Bogaert W, Lambin P. Ahmed B, et al. Anticancer Res. 2006 Jan-Feb;26(1A):307-10. Anticancer Res. 2006. PMID: 16475711 Free article.

2

Vascular targeting: a potential additional anti-cancer treatment.

Lambin P, Landuyt W. Lambin P, et al. Verh K Acad Geneeskd Belg. 2003;65(1):29-46. Verh K Acad Geneeskd Belg. 2003. PMID: 12802895 Review.

3

In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment.

Landuyt W, Ahmed B, Nuyts S, Theys J, Op de Beeck M, Rijnders A, Anné J, van Oosterom A, van den Bogaert W, Lambin P. Landuyt W, et al. Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):443-50. doi: 10.1016/s0360-3016(00)01470-x. Int J Radiat Oncol Biol Phys. 2001. PMID: 11173139

4

Combretastatin A-1 phosphate a novel tubulin-binding agent with in vivo anti vascular effects in experimental tumours.

Holwell SE, Cooper PA, Grosios K, Lippert JW 3rd, Pettit GR, Shnyder SD, Bibby MC. Holwell SE, et al. Anticancer Res. 2002 Mar-Apr;22(2A):707-11. Anticancer Res. 2002. PMID: 12017147

5

Radiosensitization of the rats' rhabdomyosarcoma R 1 by chloronitroimidazole compound--P40 dependent on radiation dose in fractionated radiotherapy.

Widel M, Watras J, Suwiński J, Salwińska E. Widel M, et al. Radiobiol Radiother (Berl). 1990;31(6):537-43. Radiobiol Radiother (Berl). 1990. PMID: 2101459

6

No effect of the hemoglobin solution HBOC-201 on the response of the rat R1H tumor to fractionated irradiation.

Raabe A, Gottschalk A, Hommel M, Dubben HH, Strandl T. Raabe A, et al. Strahlenther Onkol. 2005 Nov;181(11):730-7. doi: 10.1007/s00066-005-1418-3. Strahlenther Onkol. 2005. PMID: 16254709

7

Pentoxifylline enhances tumor oxygenation and radiosensitivity in rat rhabdomyosarcomas during continuous hyperfractionated irradiation.

Zywietz F, Böhm L, Sagowski C, Kehrl W. Zywietz F, et al. Strahlenther Onkol. 2004 May;180(5):306-14. doi: 10.1007/s00066-004-1198-1. Strahlenther Onkol. 2004. PMID: 15127161

8

Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate.

Chaplin DJ, Pettit GR, Hill SA. Chaplin DJ, et al. Anticancer Res. 1999 Jan-Feb;19(1A):189-95. Anticancer Res. 1999. PMID: 10226542

9

The vascular targeting agent combretastatin A-4-phosphate induces neutrophil recruitment to endothelial cells in vitro.

Brooks AC, Kanthou C, Cook IH, Tozer GM, Barber PR, Vojnovic B, Nash GB, Parkins CS. Brooks AC, et al. Anticancer Res. 2003 Jul-Aug;23(4):3199-206. Anticancer Res. 2003. PMID: 12926054

10

Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats.

Thoeny HC, De Keyzer F, Chen F, Ni Y, Landuyt W, Verbeken EK, Bosmans H, Marchal G, Hermans R. Thoeny HC, et al. Radiology. 2005 Mar;234(3):756-64. doi: 10.1148/radiol.2343031721. Radiology. 2005. PMID: 15734932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed